Auto logout in seconds.
Continue LogoutImproving care at the end of life is a prime opportunity for cancer programs to drive quality, decrease costs, and enhance the patient and family experience.
Aggressive end-of-life care that provides no clinical benefit, including chemotherapy and hospitalizations in the last two weeks of life, contributes significantly to overall costs of care. In addition, it often negatively impacts patients' and their families' quality of life and care experience.
While improving end-of-life care has been a longstanding priority in the oncology community, it remains challenging due to cultural and clinical barriers. To help cancer program leaders overcome these challenges, this report outlines four tactics:
Create your free account to access 1 resource, including the latest research and webinars.
You have 1 free members-only resource remaining this month.
1 free members-only resources remaining
1 free members-only resources remaining
You've reached your limit of free insights
Never miss out on the latest innovative health care content tailored to you.
You've reached your limit of free insights
Never miss out on the latest innovative health care content tailored to you.
This content is available through your Curated Research partnership with Advisory Board. Click on ‘view this resource’ to read the full piece
Email ask@advisory.com to learn more
Never miss out on the latest innovative health care content tailored to you.
This is for members only. Learn more.
Never miss out on the latest innovative health care content tailored to you.